Login / Signup

Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients.

Daniele CappellaniClaudio UrbaniChiara SardellaIlaria ScattinaGiulia MarconciniIsabella LupiLuca ManettiClaudio MarcocciFausto Bogazzi
Published in: Endocrinology, diabetes & metabolism (2018)
In acromegalic patients with controlled disease, changes in glycaemic status induced by SSAs are not permanent.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • type diabetes
  • prognostic factors
  • patient reported outcomes
  • metabolic syndrome
  • adipose tissue
  • skeletal muscle
  • weight loss
  • bone marrow
  • insulin resistance